Respiratory viral infections are a leading source of infectious complications in children undergoing hematopoietic cell transplantation and solid organ transplantation. The current diagnostic methods do not distinguish true disease or predict patients at risk for progression to severe disease. We will use a multi-faceted approach focusing on the virus and the host response to define biomarkers that risk stratify patients and generate evidence- based pediatric guidelines for personalized management.
|Effective start/end date||9/17/21 → 8/31/22|
- National Institute of Allergy and Infectious Diseases: $675,979.00
- National Institute of Allergy and Infectious Diseases: $885,241.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.